{
    "organizations": [],
    "uuid": "569ce1c99ffa93dfa50d90c03216134999e5fe17",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-integral-diagnostics-posts-hy-prof/brief-integral-diagnostics-posts-hy-profit-attributable-of-8-3-mln-idUSFWN1PD1FH",
    "ord_in_thread": 0,
    "title": "BRIEF-Integral Diagnostics Posts HY Profit Attributable Of $8.3 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 19 (Reuters) - Integral Diagnostics Ltd:\n* ‍HY PROFIT FROM ORDINARY ACTIVITIES AFTER TAX ATTRIBUTABLE TO OWNERS OF INTEGRAL DOWN 4.74% TO $8.3 MILLION\n* HY REVENUES FROM ORDINARY ACTIVITIES UP 5.65 PERCENT TO $93.6 MILLION\n* 1H18 DIVIDEND OF 4 CENTS PER SHARE FULLY FRANKED HAS BEEN DECLARED‍​\n* CAPITAL EXPENDITURE FOR THE FULL YEAR IS FORECAST AT $17 M‍LN​ Source text for Eikon: [ID:nASX4bkGpL[ Further company coverage:\n ",
    "published": "2018-01-19T06:14:00.000+02:00",
    "crawled": "2018-01-19T12:26:33.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "integral",
        "diagnostics",
        "ltd",
        "profit",
        "ordinary",
        "activity",
        "tax",
        "attributable",
        "owner",
        "integral",
        "million",
        "hy",
        "revenue",
        "ordinary",
        "activity",
        "percent",
        "million",
        "1h18",
        "dividend",
        "cent",
        "per",
        "share",
        "fully",
        "franked",
        "capital",
        "expenditure",
        "full",
        "year",
        "forecast",
        "source",
        "text",
        "eikon",
        "id",
        "nasx4bkgpl",
        "company",
        "coverage"
    ]
}